0001698865-22-000001.txt : 20220419 0001698865-22-000001.hdr.sgml : 20220419 20220419105908 ACCESSION NUMBER: 0001698865-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220419 DATE AS OF CHANGE: 20220419 EFFECTIVENESS DATE: 20220419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Accure Acne, Inc. CENTRAL INDEX KEY: 0001698865 IRS NUMBER: 814819638 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-442448 FILM NUMBER: 22833815 BUSINESS ADDRESS: STREET 1: 384 INVERNESS PARKWAY, #125 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 303-886-6125 MAIL ADDRESS: STREET 1: 384 INVERNESS PARKWAY, #125 CITY: ENGLEWOOD STATE: CO ZIP: 80112 D 1 primary_doc.xml X0708 D LIVE 0001698865 Accure Acne, Inc. 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 970-688-2498 DELAWARE None None Corporation true 2017 Christopher Carlton 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Executive Officer Director Karl Nicholls 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Executive Officer A. Edward Barbera 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Director Jeffrey O'Donnell 4699 Nautilus Court South Suite 250 Boulder CO COLORADO 80301 Director Other Health Care Decline to Disclose 06b false 2022-04-04 false true true true false 50000 Maxim Group LLC 120708 None None 300 Park Ave 16th Floor New York NY NEW YORK 10022 All States false 5000000 3500000 1500000 false 12 0 315000 true Finder's Fees: 9% of total cash consideration recieved by the Comanpy. Also issuance of warrants to purchase equity equal to 9% of total securities being sold and or issued. 0 true false Accure Acne, Inc. Christopher Carlton Christopher Carlton Chief Executive Officer 2022-04-19